Patent ID: 9610284
Date: 2017-04-04
CPC Classifications: A61K,A61P,C07D,Y02A

Claim:
1. A method of treatment of an autoimmune or inflammatory condition in a human subject in need thereof which comprises administering a therapeutically effective amount of a compound of formula (I) which is 4-(8-methoxy-1-(1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole or a pharmaceutically acceptable salt thereof; wherein said autoimmune or inflammatory condition is selected from a group consisting of a chronic autoimmune or inflammatory condition, an acute inflammatory condition, a disease or condition which involves inflammatory responses to infections with bacteria, viruses, fungi, parasites, or their toxins, and a disease associated with systemic inflammatory response syndrome.